Initial Insomnia Approximately 8% of clinical trial participants reported some degree of insomnia, primarily during the early weeks of treatment
Rybelsus (semaglutide) is FDA-approved to treat type 2 diabetes, in combination with diet and exercise
CTI scoring should be made available on Advanced Cardiometabolic & Lipid Profiles and Early Vascular & Peripheral Artery Disease Screening Panels
80 Strong value, but requires 3 month payments each order
Contact your GP or prescriber if constipation persists despite lifestyle measures for 12 weeks, or immediately if you experience severe abdominal pain, inability to pass stools or wind, rectal bleeding, persistent vomiting, or signs of bowel obstruction
Santa-Cruz Calvo and Egan (2015)